Displaying 241 - 250 of 631
This consensus statement provides a practical approach to the evaluation of incidentally discovered adrenal masses, presenting five patient case scenarios selected to highlight a unique and relatively characteristic presentation that clinicians may encounter and answering key questions to help guide evaluation, diagnosis, management, and treatment.
Read Consensus Statement moreThis statement addresses the use of somatostatin-receptor ligands (SRLs) as preoperative therapy for individuals with acromegaly to improve outcomes.
Read Consensus Statement moreThis consensus statement provides information on novel minimally invasive therapeutic interventions for thyroid malignancies such as percutaneous ethanol injection and thermal ablation. The statement summarizes existing knowledge and provides guidance on indications, techniques, complications, and follow-ups for care of patients with benign and malignant thyroid lesions.
Read Consensus Statement moreCo-sponsored by the American Head and Neck Society Endocrine Surgery Section (AHNS)
This consensus statement outlines expert opinion and practical information on the evaluation of thyroid nodules, surgical considerations, and postoperative monitoring for children and adolescents with benign and malignant thyroid lesions.
Read Consensus Statement more
Co-sponsored by the American Association for the Study of Liver Diseases (AASLD)
This guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders.
Read Guideline
AACE Podcasts Episode 31:
Listen to endocrine expert Vin Tangpricha, M.D., Ph.D., as he interviews AACE Co-…
more
Algorithm
Type 2 Diabetes
In process
Guideline
Postmenopausal Osteoporosis
In process
Consensus Statement
Diabetes Technology
In process
Consensus Statement
Thyroid Cancer Survivorship
2026 Empanelment
Algorithm
MASLD
2026 Empanelment
moreOnly topics nominated by AACE members in good standing will be considered.Members may submit topic nominations at any time; however, they will be reviewed by the Clinical Practice Guidelines (CPG) Oversight Committee twice annually.
- To be considered during the Spring review, submissions must be received by January 8, 2026.
- To be considered during the Fall review, submissions must be received by July 16, 2026.
Nominators will be notified of the committee’s decision following the applicable review meeting.Approval does not ensure development within a set timeframe.…
more
2020 Algorithm on the Management of Dyslipidemia and Prevention of Cardiovascular Disease
2020 Comprehensive Type 2 Diabetes Mellitus Algorithm
2019 Comprehensive Type 2 Diabetes Mellitus Algorithm
2018 Comprehensive Type 2 Diabetes Mellitus Algorithm
2018 Position Statement on Dysglycemia-Based Chronic Disease
2018 Position Statement on Integration of Insulin Pumps and Continuous Glucose Monitoring in Patients with Diabetes Mellitus
2017 Clinical Practice Guideline for the Management of Dyslipidemia and Prevention of Cardiovascular Disease
2017…
moreChair and Author Qualifications to Serve on a Guidance Document Task Force
To be considered to serve as a Chair/Co-Chair/Vice Chair or an author of an AACE guideline or consensus statement for a particular task force, AACE members must complete an application and a disclosure form, submit their curriculum vitae, and meet the following qualifications:
Required qualifications
- Current AACE member in good standing
- Active in practice within last 5 years
- Publications:
- Chairs: Two (first or senior author) publications on the…
moreAnswers to the most frequently asked questions.
What is an AACE clinical practice guideline?
AACE clinical practice guidelines aim to provide trustworthy, evidence-based recommendations regarding clinical practice to improve the care of individuals with endocrine diseases and disorders. Recommendations in AACE guidelines are informed by systematic reviews and unbiased assessment of evidence, benefits, and harms.…
more
